CH
NYMX

CVI Holdings’s Nymox Pharmaceutical Corp NYMX Stock Holding History

CVI Holdings’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45,993
Closed -$58K – 983
2022
Q1 		$58K Buy
+45,993
New +$71K ﹤0.01% 593

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

CVI Holdings's NYMX Position: Q2 2022 in Review

CVI Holdings sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2022, closing a stake of 45,993 shares — an estimated $58K sold.

CVI Holdings first reported a position in NYMX in Q1 2022 and held it in 1 quarter. The position peaked at $58K in Q1 2022. 39 funds tracked by Wall St. Rank hold NYMX as of Q2 2022.

  • CVI Holdings reported no remaining Nymox Pharmaceutical Corp position as of Q2 2022 after selling out during the quarter.
  • CVI Holdings sold 45,993 Nymox Pharmaceutical Corp shares in Q2 2022, an estimated $58K.
  • CVI Holdings first reported a position in Nymox Pharmaceutical Corp in Q1 2022 and held it in 1 quarter.
  • CVI Holdings's Nymox Pharmaceutical Corp position peaked at $58K in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2022.

Based on CVI Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.